ClinConnect ClinConnect Logo
Search / Trial NCT06072014

ImGTS for Patients With Behavioral and Psychological Symptoms of Dementia (Phase 2)

Launched by AUGMENTED EXPERIENCE E-HEALTH LABORATORY · Oct 5, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help manage the behavioral and psychological symptoms that can occur with Alzheimer's disease, using immersive technology. This means they are creating a special system that uses virtual reality or similar technology to see if it can effectively improve the well-being of patients with mild to moderate Alzheimer's. The researchers want to find out if this technology is safe, easy to use, and accepted by the patients.

To participate in this study, individuals need to be 60 years or older and diagnosed with mild to moderate Alzheimer's disease. They should also be able to walk with little assistance and have stable medication doses for their mood or mental health. The trial is currently recruiting participants, and those who take part can expect to engage with the immersive technology system and help the researchers understand if it could be a beneficial tool for managing symptoms of dementia. It’s important to know that some people, like those with certain cognitive impairments or serious health issues, may not be eligible to join.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Aged 60 years old or older
  • Diagnosed with mild to moderate Alzheimer's dementia according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria
  • Montreal Cognitive Assessment-Philippines (MOCA-P) score of 10-20 inclusive
  • Neuropsychiatric Inventory (NPI-12) score 1-50 inclusive
  • Reisberg Scale Stage 4-5 inclusive
  • Stable dose of antidepressants for the past 6 weeks
  • Stable dose of antipsychotics for the past 4 weeks
  • Able to walk unassisted or with minimal assistance, with or without assistive device
  • No other explanation for condition based on reasonable clinical diagnostics
  • Exclusion Criteria:
  • Have mild cognitive impairment (no dementia)
  • Have MOCA-P score less than 10 or more than 20
  • Other non-amnestic dementia syndromes
  • Have receptive aphasia
  • Have significant visual or hearing impairment
  • Have an active psychiatric disorder prior to Alzheimer dementia diagnosis
  • Had previous episodes of seizures, diagnosis of epilepsy, or intake of antiepileptic or seizure medications
  • Have quadriplegia or paralysis of the dominant hand
  • Have a history of motion sickness
  • Experience claustrophobia
  • Have a diagnosis of a terminal illness or a life expectancy of less than one year

About Augmented Experience E Health Laboratory

Augmented Experience e-Health Laboratory is a pioneering clinical trial sponsor dedicated to advancing healthcare through innovative digital solutions and augmented reality technologies. Our mission is to enhance patient engagement and streamline clinical research processes by leveraging cutting-edge e-health tools. With a focus on improving outcomes and accessibility, we collaborate with healthcare providers, researchers, and technology experts to develop and implement evidence-based interventions. Our commitment to rigorous scientific standards and patient-centered approaches positions us at the forefront of transforming the landscape of clinical trials and e-health initiatives.

Locations

City Of Manila, National Capital Region, Philippines

Patients applied

0 patients applied

Trial Officials

Veeda Michelle M. Anlacan, MD

Principal Investigator

University of the Philippines Manila

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported